Cefdinir
Product Images NDC 67296-1291

1 FDA label image from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Cefdinir (NDC 67296-1291). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Cefdinir 300mg (Doc20170517161229 001)

Cefdinir 300mg (Doc20170517161229 001)
Two label panels for Cefdinir 300mg capsules by RedPharm Drug, Inc. The first label is for 20 capsules with NDC 67296-1291-2, lot 11F0071, expiring 08/17. The second label is for 10 capsules with NDC 67296-1291-1, lot 11F0072, expiring 08/17. Both labels note Rx only status, usual adult dosage directs to package insert, storage at controlled room temperature, and manufacturing by Hospira Healthcare India Pvt Ltd.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.